Sale!

MECP2 Gene Encephalopathy neonatal severe Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MECP2 Gene Encephalopathy Neonatal Severe Genetic Test” is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect mutations in the MECP2 gene, which are associated with severe neurological disorders manifesting shortly after birth. MECP2 gene mutations are primarily linked to Rett syndrome and other related encephalopathies, which can severely impact an individual’s neurological development and function. These conditions often present with symptoms such as intellectual disability, motor challenges, communication difficulties, and sometimes, seizures.

The test involves analyzing the patient’s DNA to identify any abnormalities in the MECP2 gene that could lead to these severe conditions. It is particularly crucial for early diagnosis and management of the symptoms, allowing for tailored therapies and interventions that can significantly improve the quality of life for affected individuals and their families.

Priced at 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost reflects the sophisticated technology and expertise required to accurately diagnose such complex genetic conditions. By choosing this test, patients and healthcare providers are taking a critical step towards understanding and managing MECP2 gene-related encephalopathies, armed with the knowledge necessary for personalized treatment planning.

Description

MECP2 Gene Encephalopathy Neonatal Severe Genetic Test

Welcome to DNA Labs UAE, your trusted genetic testing laboratory. In this blog post, we will discuss the MECP2 Gene Encephalopathy Neonatal Severe Genetic Test, including its cost, symptoms, diagnosis, and more.

Test Name: MECP2 Gene Encephalopathy Neonatal Severe Genetic Test

Components: MECP2 gene analysis

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MECP2 Gene Encephalopathy Neonatal Severe NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MECP2 Gene Encephalopathy Neonatal Severe.

About MECP2 Gene Encephalopathy Neonatal Severe

MECP2 gene encephalopathy neonatal severe (ENS) is a rare genetic disorder that affects the brain and nervous system. It is caused by mutations in the MECP2 gene, which provides instructions for making a protein called methyl-CpG-binding protein 2 (MeCP2). MeCP2 is important for normal brain development and function, and mutations in the MECP2 gene can lead to a range of neurological problems.

NGS Technology for Genetic Testing

NGS (next-generation sequencing) genetic testing is a method of analyzing DNA to identify mutations in specific genes, including the MECP2 gene. This type of testing can help diagnose ENS and other genetic disorders, as well as identify carriers of genetic mutations. NGS testing typically involves collecting a small sample of blood or saliva, which is then analyzed in a laboratory using advanced sequencing technology.

Benefits of MECP2 Gene Encephalopathy Neonatal Severe Genetic Test

The results of the test can provide important information about an individual’s risk of developing ENS or passing on the mutation to their children. Early diagnosis and treatment of ENS is important for managing symptoms and improving outcomes. NGS genetic testing can help identify individuals with the condition and provide guidance for medical management and family planning.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. If you suspect that you or your loved one may have MECP2 gene encephalopathy neonatal severe, consult with a neurologist and consider undergoing the MECP2 Gene Encephalopathy Neonatal Severe Genetic Test for a comprehensive evaluation.

Test Name	MECP2 Gene Encephalopathy neonatal severe Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for MECP2 Gene Encephalopathy neonatal severe NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MECP2 Gene Encephalopathy neonatal severe
Test Details	MECP2 gene encephalopathy neonatal severe (ENS) is a rare genetic disorder that affects the brain and nervous system. It is caused by mutations in the MECP2 gene, which provides instructions for making a protein called methyl-CpG-binding protein 2 (MeCP2). MeCP2 is important for normal brain development and function, and mutations in the MECP2 gene can lead to a range of neurological problems. NGS (next-generation sequencing) genetic testing is a method of analyzing DNA to identify mutations in specific genes, including the MECP2 gene. This type of testing can help diagnose ENS and other genetic disorders, as well as identify carriers of genetic mutations. NGS testing typically involves collecting a small sample of blood or saliva, which is then analyzed in a laboratory using advanced sequencing technology. The results of the test can provide important information about an individual’s risk of developing ENS or passing on the mutation to their children. Early diagnosis and treatment of ENS is important for managing symptoms and improving outcomes. NGS genetic testing can help identify individuals with the condition and provide guidance for medical management and family planning.

Browse

Want to chat?

Social